| Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent (NCT05431725) | Sinovac Biotech Co., Ltd | 2022-07-18 |
| A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults (NCT05415462) | ModernaTX, Inc. | 2022-06-06 |
| A Study of Modified mRNA Vaccines in Healthy Adults (NCT05397223) | ModernaTX, Inc. | 2022-05-24 |
| A Study of mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccines in Healthy Adults (NCT05333289) | ModernaTX, Inc. | 2022-04-06 |
| A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old (NCT04997239) | Sinovac Biotech Co., Ltd | 2021-10-10 |
| A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults (NCT04956575) | ModernaTX, Inc. | 2021-07-06 |
| First-in-Human Clinical Trial of a Mosaic Quadrivalent Influenza Vaccine Compared With a Licensed Inactivated Seasonal QIV in Healthy Adults (NCT04896086) | National Institute of Allergy and Infectious Diseases (NIAID) | 2021-05-24 |
| The Immunogenicity and Safety of the Vaccination of Inactivated Enterovirus 71 Vaccine and Seasonal Influenza Vaccine (NCT04133584) | Zhejiang Provincial Center for Disease Control and Prevention | 2019-09-16 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (7.5μg/0.25ml) (NCT03859141) | Sinovac Biotech Co., Ltd | 2018-02-06 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of Quadrivalent Influenza Vaccine (15µg/0.5ml) (NCT03853993) | Sinovac Biotech Co., Ltd | 2018-01-23 |
| A Phase I Study of Candidate Influenza Vaccines MVA-NP+M1 and ChAdOx1 NP+M1 (NCT01818362) | University of Oxford | 2013-04-01 |
| Immunogenicity of Seasonal Influenza by Delivery Directly to Ileum (NCT01761123) | Vaxart | 2013-01-01 |
| Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects (NCT01342796) | Novartis Vaccines | 2011-05-01 |
| Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2011-2012 (NCT01344057) | Novartis Vaccines | 2011-05-01 |
| Safety and Immunogenicity of Trivalent Subunit Inactivated Flu Vaccine Administered to Healthy Children and Adolescents 3 to 17 Years of Age (NCT01209780) | Novartis Vaccines | 2010-09-01 |
| Evaluation of Seasonal Influenza Vaccine for 2010-2011 in Young Children (NCT01180621) | Dalhousie University | 2010-09-01 |
| Yearly Strain Variation Study, 2010/2011 (NCT01157702) | Alachua Government Services, Inc. | 2010-07-01 |
| Safety and Immunogenicity of One Dose of Inactivated Trivalent Flu Vaccine Administered to Non-elderly Adult and Elderly Subjects (NCT01151059) | Novartis Vaccines | 2010-06-01 |
| Study to Evaluate Safety and Immunogenicity of Sub-unit Adjuvanted Influenza Vaccine Administered to Elderly Subjects, Formulation 2010-2011 (NCT01152814) | Novartis Vaccines | 2010-06-01 |
| Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011 (NCT01147081) | Novartis Vaccines | 2010-06-01 |
| Evaluating the Safeness of Trivalent Subunit Inactivated Influenza Vaccines in Preventing Flu on Vietnamese Volunteers (NCT01123954) | Novartis Vaccines | 2010-01-01 |
| A Study to Evaluate the Efficacy and Safety of IV Peramivir in Addition to Standard of Care Compared to Standard of Care Alone in Adults and Adolescents Who Are Hospitalized Due to Influenza (NCT00958776) | BioCryst Pharmaceuticals | 2009-11-01 |
| Safety and Immunogenicity of an A (H1N1) 2009 Influenza Virus-like Particle (VLP) Vaccine (NCT01072799) | Novavax | 2009-10-01 |
| The Effect of a Planning Prompt on Seasonal Influenza Vaccination Rates (NCT01207232) | University of Pennsylvania | 2009-10-01 |
| Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza (NCT00957996) | BioCryst Pharmaceuticals | 2009-10-01 |
| The Effect of Time-Slot Scheduling on Flu Vaccination Rates (NCT01206686) | University of Pennsylvania | 2009-09-01 |
| Safety and Immunogenicity of Influenza Vaccine (Surface Antigen, Inactivated) [Ph.Eur], Formulation 2009-2010, When Administered to Non-Elderly Adult and Elderly Subjects (NCT00956449) | Novartis | 2009-06-01 |
| Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2009/2010 (NCT00945841) | Novartis | 2009-06-01 |
| Safety and Immunogenicity of a Surface Antigen, Inactivated, Adjuvanted With MF59C.1, Seasonal Influenza Vaccine, Formulation 2009-2010 (NCT00956761) | Novartis | 2009-06-01 |
| Yearly Strain Variation Study, 2009/2010 (NCT00943657) | Alachua Government Services, Inc. | 2009-06-01 |
| Trial to Evaluate Safety and Immunogenicity of Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) (NCT00903552) | Novavax | 2009-05-01 |
| Safety and Immunogenicity of Surface Antigen, Inactivated, Influenza Vaccine Using the Strain Composition 2008/2009 (NCT00748813) | Novartis Vaccines | 2008-06-01 |
| Safety and Immunogenicity of Trivalent Split Influenza Vaccine Using the Strain Composition 2007/2008 (NCT00498303) | Novartis | 2007-06-01 |